Knut Brockow Selected Research

Coloring Agents (Dyes)

1/2022	Allergy to Radiocontrast Dye.
1/2020	Adverse reactions during procedures: Hypersensitivity to contrast agents and dyes.
8/2014	Hypersensitivity to contrast media and dyes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Knut Brockow Research Topics

Disease

72	Hypersensitivity (Allergy) 12/2024 - 01/2002
47	Anaphylaxis (Anaphylactic Shock) 10/2023 - 01/2004
21	Mastocytosis 10/2023 - 01/2002
14	Drug Hypersensitivity (Drug Allergy) 11/2022 - 01/2004
8	Neoplasms (Cancer) 12/2024 - 08/2003
8	Systemic Mastocytosis 04/2024 - 08/2003
8	Exercise-Induced Allergies 10/2023 - 04/2015
7	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2002
6	COVID-19 12/2024 - 11/2020
5	Urticaria (Hives) 03/2024 - 01/2021
5	Chronic Urticaria 02/2024 - 01/2011
5	Mast Cell Activation Disorders (Mast-Cell Disease) 10/2023 - 08/2012
5	Food Hypersensitivity (Food Allergy) 10/2023 - 01/2020
5	Hereditary alpha-tryptasemia syndrome 10/2023 - 11/2020
5	Asthma (Bronchial Asthma) 10/2021 - 01/2010
4	Immediate Hypersensitivity 11/2022 - 01/2006
4	Mast Cell Activation Syndrome 01/2022 - 01/2013
3	Bites and Stings (Sting) 01/2023 - 01/2019
3	Osteoporosis 01/2021 - 01/2002
3	Inflammation (Inflammations) 11/2020 - 05/2006
2	Mast-Cell Leukemia (Leukemia, Mast Cell) 04/2024 - 08/2003
2	Angioedema 02/2024 - 04/2012
2	Allergic Rhinitis 10/2021 - 01/2020
2	Syphilis 04/2021 - 01/2021
2	Eosinophilic Esophagitis 01/2020 - 08/2014
1	Venom Hypersensitivity 04/2024
1	Cutaneous Mastocytosis 04/2024
1	Leukocytosis (Pleocytosis) 04/2024
1	Wheat Hypersensitivity (Wheat Allergy) 03/2024
1	Melanoma (Melanoma, Malignant) 03/2024
1	Chronic Inducible Urticaria 02/2024
1	Abnormal Karyotype 01/2023
1	Reinfection 11/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2022
1	Eosinophilia 02/2022

Drug/Important Bio-Agent (IBA)

33	Immunoglobulin E (IgE)IBA 10/2023 - 01/2002
23	Tryptases (Tryptase)IBA 04/2024 - 01/2002
16	Contrast MediaIBA 07/2022 - 04/2005
15	VaccinesIBA 12/2024 - 11/2012
13	Arthropod VenomsIBA 04/2024 - 01/2004
13	AllergensIBA 01/2023 - 01/2004
7	COVID-19 VaccinesIBA 01/2023 - 01/2021
6	Penicillins (Penicillin)FDA Link 05/2024 - 01/2020
6	Glutens (Glutelin)IBA 03/2024 - 04/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2014
5	LactamsIBA 01/2022 - 10/2014
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2024 - 01/2022
4	mRNA VaccinesIBA 12/2024 - 01/2022
4	Omalizumab (Xolair)FDA Link 01/2023 - 01/2020
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 01/2010
4	VenomsIBA 01/2023 - 01/2014
4	beta-LactamsIBA 11/2022 - 01/2020
4	GliadinIBA 08/2021 - 04/2015
3	Indicators and Reagents (Reagents)IBA 04/2024 - 01/2010
3	CytokinesIBA 03/2024 - 05/2006
3	Histamine (Histamine Dihydrochloride)FDA Link 02/2024 - 01/2010
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
3	EpitopesIBA 01/2022 - 09/2020
3	Coloring Agents (Dyes)IBA 01/2022 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2005
3	AntibodiesIBA 09/2020 - 01/2004
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2024 - 01/2014
2	Histamine Receptors (Histamine Receptor)IBA 02/2024 - 03/2021
2	beta Lactam AntibioticsIBA 12/2023 - 01/2020
2	anti-IgE antibodiesIBA 01/2023 - 01/2020
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	dupilumabIBA 01/2021 - 01/2021
2	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2020 - 01/2020
2	SteroidsIBA 01/2020 - 08/2014
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2019
2	Eosinophil Cationic ProteinIBA 08/2014 - 01/2003
2	GadoliniumIBA 08/2014 - 08/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2008 - 05/2006
2	Interleukin-6 (Interleukin 6)IBA 05/2005 - 01/2002
1	BNT162 VaccineIBA 12/2024
1	Lipid NanoparticlesIBA 12/2024
1	Immune Checkpoint InhibitorsIBA 03/2024
1	Cholinergic Agents (Cholinergics)IBA 02/2024
1	Prostaglandins AIBA 02/2024
1	Proton Pump InhibitorsIBA 11/2023
1	lipid transfer protein (glycolipid transfer protein)IBA 10/2023
1	5-chloro-2-methyl-4-isothiazolin-3-oneIBA 01/2023
1	Polysorbates (PSML)FDA Link 01/2023
1	midostaurinIBA 01/2023
1	Bee Venoms (Bee Venom)IBA 01/2023
1	2-methyl-4-isothiazolin-3-oneIBA 01/2023
1	Monoclonal AntibodiesIBA 02/2022
1	venetoclaxIBA 02/2022
1	S63845IBA 02/2022
1	Tyrosine Kinase InhibitorsIBA 02/2022

Therapy/Procedure

24	Therapeutics 03/2024 - 10/2004
4	Injections 01/2022 - 09/2019
4	Premedication 01/2022 - 04/2005
3	Immunotherapy 12/2024 - 01/2004
2	Off-Label Use 01/2023 - 11/2020
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020